Articles by Disease (Coronavirus Collection)

Identification of Main Protease of Coronavirus SARS-CoV-2 (M^pro) Inhibitors from Melissa officinalis

Journal: Current Drug Discovery Technologies
Volume: 18
Page: 5-19
Author(s): Olusola O. Elekofehinti*, Opeyemi Iwaloye, Courage D. Famusiwa, Olanrewaju Akinseye and Joao B. T. Rocha

Quercetin and its Relative Therapeutic Potential Against COVID-19: A Retrospective Review and Prospective Overview

Journal: Current Molecular Medicine
Volume: 21
Page: 385-391
Author(s): Saiyad Bastaminejad and Salar Bakhtiyari*

Remdesivir (GS-5734) in COVID-19 Therapy: The Fourth Chance

Journal: Current Drug Targets
Volume: 22
Page: 1346-1356
Author(s): Dinesh S. Moirangthem and Laishram Surbala*

Nanocarriers in the Delivery of Hydroxychloroquine to the Respiratory System: An Alternative to COVID-19

Journal: Current Drug Delivery
Volume: 18
Page: 583-595
Author(s): Iago Dillion Lima Cavalcanti*, Sandrelli Meridiana de Fátima Ramos dos Santos Medeiros, Daniel Charles dos Santos Macêdo, Isabella Macário Ferro Cavalcanti and Mariane Cajubá de Britto Lira Nogueira*

Efficacy of Dexamethasone for the Treatment of COVID-19 Infection: A Perspective Review

Journal: Current Drug Delivery
Volume: 18
Page: 546-554
Author(s): Shadma Wahab*, Irfan Ahmad, Shazia Usmani and Md. Parwez Ahmad

Diabetes and COVID-19; a Review of Possible Mechanisms

Journal: Current Pharmaceutical Design
Volume: 27
Page: 2522-2527
Author(s): Reyhaneh Moradi-Marjaneh, Fereshteh Asgharzadeh, Elnaz Khordad and Mahdi Moradi Marjaneh*

The Binding of Remdesivir to SARS-CoV-2 RNA-Dependent RNA Polymerase May Pave The Way Towards the Design of Potential Drugs for COVID-19 Treatment

Journal: Current Pharmaceutical Biotechnology
Volume: 22
Page: 1520-1537
Author(s): Clement Agoni and Mahmoud E.S. Soliman*